BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 25895526)

  • 1. Incidence and Risk Factors for Urolithiasis in Patients with Crohn's Disease.
    Kim MJ; Woo SY; Kim ER; Hong SN; Chang DK; Rhee PL; Kim JJ; Rhee JC; Kim YH
    Urol Int; 2015; 95(3):314-9. PubMed ID: 25895526
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of urolithiasis in Crohn's disease in Tunisian patients.
    Boussorra H; Sallami S; Said Y; Chebil M; Najjar T
    Tunis Med; 2013 Jul; 91(7):440-3. PubMed ID: 24008874
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical evaluation of urolithiasis in Crohn's disease.
    Ishii G; Nakajima K; Tanaka N; Hara H; Kato M; Ishii N
    Int J Urol; 2009 May; 16(5):477-80. PubMed ID: 19341366
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Early azathioprine/biological therapy is associated with decreased risk for first surgery and delays time to surgery but not reoperation in both smokers and nonsmokers with Crohn's disease, while smoking decreases the risk of colectomy in ulcerative colitis.
    Szamosi T; Banai J; Lakatos L; Czegledi Z; David G; Zsigmond F; Pandur T; Erdelyi Z; Gemela O; Papp M; Papp J; Lakatos PL
    Eur J Gastroenterol Hepatol; 2010 Jul; 22(7):872-9. PubMed ID: 19648821
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The relationship between inflammatory bowel disease (IBD) and complications of urinary and male genital tracts].
    Yumura Y; Oota J; Fujikawa A; Yokomizo Y; Moriyama M
    Hinyokika Kiyo; 2009 Nov; 55(11):677-83. PubMed ID: 19946184
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Urolithiasis and urinary tract infection among patients with inflammatory bowel disease: a review of US emergency department visits between 2006 and 2009.
    Varda BK; McNabb-Baltar J; Sood A; Ghani KR; Kibel AS; Letendre J; Menon M; Sammon JD; Schmid M; Sun M; Trinh QD; Bhojani N
    Urology; 2015 Apr; 85(4):764-70. PubMed ID: 25669736
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phenotypic features of Crohn's disease associated with failure of medical treatment.
    Moran GW; Dubeau MF; Kaplan GG; Yang H; Seow CH; Fedorak RN; Dieleman LA; Barkema HW; Ghosh S; Panaccione R;
    Clin Gastroenterol Hepatol; 2014 Mar; 12(3):434-42.e1. PubMed ID: 23978351
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Crohn's disease and ulcerative colitis. Occurrence, course and prognosis during the first year of disease in a European population-based inception cohort.
    Burisch J
    Dan Med J; 2014 Jan; 61(1):B4778. PubMed ID: 24393595
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk factors for urolithiasis in patients with Crohn's disease.
    Miyajima S; Ishii T; Watanabe M; Ueki T; Tanaka M
    Int J Urol; 2021 Feb; 28(2):220-224. PubMed ID: 33191551
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Birth outcome in women with ulcerative colitis and Crohn's disease, and pharmacoepidemiological aspects of anti-inflammatory drug therapy.
    Nørgård BM
    Dan Med Bull; 2011 Dec; 58(12):B4360. PubMed ID: 22142578
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The risk of colorectal cancer in inflammatory bowel disease: a hospital-based cohort study from Korea.
    Lee HS; Park SH; Yang SK; Ye BD; Kim JH; Kim SO; Soh JS; Lee S; Bae JH; Lee HJ; Yang DH; Kim KJ; Byeon JS; Myung SJ; Yoon YS; Yu CS; Kim JH
    Scand J Gastroenterol; 2015 Feb; 50(2):188-96. PubMed ID: 25515241
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The impact of thiopurines on the risk of surgical recurrence in patients with Crohn's disease after first intestinal surgery.
    Papay P; Reinisch W; Ho E; Gratzer C; Lissner D; Herkner H; Riss S; Dejaco C; Miehsler W; Vogelsang H; Novacek G
    Am J Gastroenterol; 2010 May; 105(5):1158-64. PubMed ID: 20010925
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Has there been a change in the natural history of Crohn's disease? Surgical rates and medical management in a population-based inception cohort from Western Hungary between 1977-2009.
    Lakatos PL; Golovics PA; David G; Pandur T; Erdelyi Z; Horvath A; Mester G; Balogh M; Szipocs I; Molnar C; Komaromi E; Veres G; Lovasz BD; Szathmari M; Kiss LS; Lakatos L
    Am J Gastroenterol; 2012 Apr; 107(4):579-88. PubMed ID: 22233693
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acute pancreatitis in inflammatory bowel disease, with special reference to azathioprine-induced pancreatitis.
    Bermejo F; Lopez-Sanroman A; Taxonera C; Gisbert JP; Pérez-Calle JL; Vera I; Menchén L; Martín-Arranz MD; Opio V; Carneros JA; Van-Domselaar M; Mendoza JL; Luna M; López P; Calvo M; Algaba A
    Aliment Pharmacol Ther; 2008 Sep; 28(5):623-8. PubMed ID: 18513380
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Azathioprine as a postoperative prophylaxis reduces symptoms in aggressive Crohn's disease.
    Myrelid P; Svärm S; Andersson P; Almer S; Bodemar G; Olaison G
    Scand J Gastroenterol; 2006 Oct; 41(10):1190-5. PubMed ID: 16990204
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epidemiology and risk factors in urolithiasis.
    Bartoletti R; Cai T; Mondaini N; Melone F; Travaglini F; Carini M; Rizzo M
    Urol Int; 2007; 79 Suppl 1():3-7. PubMed ID: 17726345
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Risk factors and characteristics of gut microbiota and metabolites in inflammatory bowel diseases patients with urolithiasis].
    Shi YJ; Yu S; Tian BW; Dai YM; Xu H; Tan B; Li Y
    Zhonghua Yi Xue Za Zhi; 2022 Nov; 102(44):3525-3531. PubMed ID: 36418251
    [No Abstract]   [Full Text] [Related]  

  • 18. [Risk of lithiasis and urolithiasis in children with unspecific inflammatory bowel disease].
    Makosiej R; Czkwianianc E; Niedworok M; Małecka-Panas E
    Pol Merkur Lekarski; 2007 May; 22(131):410-3. PubMed ID: 17679383
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk factors for initial surgery in patients with Crohn's disease in Central China.
    Chen M; Yi F; Zhou F; Huang M; Li J; Yan W; Li L; Xia B
    Surg Today; 2015 Aug; 45(8):1002-8. PubMed ID: 25524561
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical characteristics of inflammatory bowel disease in Turkey: a multicenter epidemiologic survey.
    Tozun N; Atug O; Imeryuz N; Hamzaoglu HO; Tiftikci A; Parlak E; Dagli U; Ulker A; Hulagu S; Akpinar H; Tuncer C; Suleymanlar I; Ovunc O; Hilmioglu F; Aslan S; Turkdogan K; Bahcecioglu HI; Yurdaydin C;
    J Clin Gastroenterol; 2009 Jan; 43(1):51-7. PubMed ID: 18724251
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.